Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 86.27

+6.0%

Jan 7 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: mlkr who wrote (2928)	8/26/2010 11:51:09 AM
From: Jibacoa	of 3722

MRNA is trying to move up after forming a base at the $2.55 level.<g> The stock is up 9.66% with volume now > 3/4 its ADV bigcharts.marketwatch.com MRNA announced today that it has entered into an Agreement with CYPB under which CYPB will acquire MMRNA's patent rights and technology related to Carbetocin. MRNA will receive an upfront payment of $750,000 and potential milestone payments up to $27M and CYPB will be responsible for all future development and related expenses and will pay MRNA royalties on commercial sales. MRNA's CEO said: "The sale of our Carbetocin assets is another example of our efforts to monetize the legacy assets of our predecessor company while we remain focused on building value around our RNAi drug discovery platforms." Now have to watch the resistance at the $4 level.<g> Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next